@article{eef11d41fcf54386878586948d95b31e,
title = "Five years of caplacizumab – lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura",
keywords = "ADAMTS-13 protein, autoimmune disease, immune-mediated thrombotic thrombocytopenic purpura, single-domain antibodies",
author = "V{\"o}lker, \{Linus Alexander\} and Brinkkoetter, \{Paul Thomas\} and Cataland, \{Spero R.\} and Camila Masias",
note = "Publisher Copyright: {\textcopyright} 2023 International Society on Thrombosis and Haemostasis",
year = "2023",
month = oct,
doi = "10.1016/j.jtha.2023.07.027",
language = "English",
volume = "21",
pages = "2718--2725",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
number = "10",
}